ORANU IBEKIE: Open Payments
NPI 1134190713 · MERRILLVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$418 in 16 payments from 10 companies in 2025. Trend: 2023 $625 · 2024 $404 · 2025 $418
Food & beverage: $418
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 1 | $111 |
| Otsuka America Pharmaceutical, Inc. | 5 | $108 |
| Indivior Inc. | 2 | $38 |
| Novo Nordisk Inc | 1 | $30 |
| Neurocrine BioSciences, Inc. | 2 | $28 |
| Exact Sciences Corporation | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Lundbeck LLC | 1 | $22 |
| Braeburn Inc. | 1 | $20 |
| Orexo US, Inc. | 1 | $15 |
Products named: REXULTI, Vemlidy, SUBLOCADE, Wegovy, INGREZZA, Cologuard Collection Kit, CAPLYTA, BRIXADI.
Industry payments across IN — which companies pay providers there.
